Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment

Clinical trial NCT05435352 · TERMINATED

Trial details

NCT number: NCT05435352
Sponsor: Ourotech, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Triple Negative Breast Cancer Triple Negative Breast Neoplasms

Start date: 2022-06-06
Primary completion: 2025-07-25
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.